TY - JOUR
T1 - The clinical presentation and genotype of protein C deficiency with double mutations of the protein C gene
AU - Inoue, Hirofumi
AU - Terachi, Shin Ichi
AU - Uchiumi, Takeshi
AU - Sato, Tetsuji
AU - Urata, Michiyo
AU - Ishimura, Masataka
AU - Koga, Yui
AU - Hotta, Taeko
AU - Hara, Toshiro
AU - Kang, Dongchon
AU - Ohga, Shouichi
N1 - Funding Information:
We thank Dr. Brian Quinn (Editor-in-Chief of Japan Medical Communication) for editing the manuscript. This work was supported by Grants-in-Aid for Scientific Research (Research on Intractable Diseases) from the Ministry of Health, Labor and Welfare of Japan. The contributions of each author are as follows. HI and SO were the principal investigators, taking primary responsibility for the paper. ST, TS, MI, and TH performed the clinical management with helpful discussion regarding the completion of the work. MU completed the genetic analysis. YK, TH, and TU managed the quality control of the screening of thrombophilic predisposition. SO and DK organized the nationwide cohort of pediatric thrombophilia in Japan. The authors declare that there is no conflict of interest.
Publisher Copyright:
© 2017 Wiley Periodicals, Inc.
PY - 2017/7
Y1 - 2017/7
N2 - Background: Severe protein C (PC) deficiency is a rare heritable thrombophilia leading to thromboembolic events during the neonatal period. It remains unclear how individuals with complete PC gene (PROC) defects develop or escape neonatal stroke or purpura fulminans (PF). Procedure: We studied the onset of disease and the genotype of 22 PC-deficient patients with double mutations in PROC based on our cohort (n = 12) and the previous reports (n = 10) in Japan. Results: Twenty-two patients in 20 unrelated families had 4 homozygous and 18 compound heterozygous mutations. Sixteen newborns presented with PF (n = 11, 69%), intracranial thromboembolism and hemorrhage (n = 13, 81%), or both (n = 8, 50%), with most showing a plasma PC activity of <10%. Six others first developed overt thromboembolism when they were over 15 years of age, showing a median PC activity of 31% (range: 19–52%). Fifteen of the 22 patients (68%) had the five major mutations (G423VfsX82, V339M, R211W, M406I, and F181V) or two others (E68K and K193del) that have been reported in Japan. Three of the six late-onset cases, but none of the 16 neonatal cases, had the K193del mutation, which has been reported to be the most common variant of Chinese thrombophilia. A novel mutation of A309V was determined in a family of two patients with late onset. Conclusions: The genotype of double-PROC mutants might show less diversity than heterozygous mutants in terms of the timing of the onset of thrombophilia (newborn onset or late onset).
AB - Background: Severe protein C (PC) deficiency is a rare heritable thrombophilia leading to thromboembolic events during the neonatal period. It remains unclear how individuals with complete PC gene (PROC) defects develop or escape neonatal stroke or purpura fulminans (PF). Procedure: We studied the onset of disease and the genotype of 22 PC-deficient patients with double mutations in PROC based on our cohort (n = 12) and the previous reports (n = 10) in Japan. Results: Twenty-two patients in 20 unrelated families had 4 homozygous and 18 compound heterozygous mutations. Sixteen newborns presented with PF (n = 11, 69%), intracranial thromboembolism and hemorrhage (n = 13, 81%), or both (n = 8, 50%), with most showing a plasma PC activity of <10%. Six others first developed overt thromboembolism when they were over 15 years of age, showing a median PC activity of 31% (range: 19–52%). Fifteen of the 22 patients (68%) had the five major mutations (G423VfsX82, V339M, R211W, M406I, and F181V) or two others (E68K and K193del) that have been reported in Japan. Three of the six late-onset cases, but none of the 16 neonatal cases, had the K193del mutation, which has been reported to be the most common variant of Chinese thrombophilia. A novel mutation of A309V was determined in a family of two patients with late onset. Conclusions: The genotype of double-PROC mutants might show less diversity than heterozygous mutants in terms of the timing of the onset of thrombophilia (newborn onset or late onset).
UR - http://www.scopus.com/inward/record.url?scp=85019572396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019572396&partnerID=8YFLogxK
U2 - 10.1002/pbc.26404
DO - 10.1002/pbc.26404
M3 - Article
C2 - 28111891
AN - SCOPUS:85019572396
SN - 1545-5009
VL - 64
JO - Medical and Pediatric Oncology
JF - Medical and Pediatric Oncology
IS - 7
M1 - e26404
ER -